Haoxi Health Technology (HAO) Registration Filing summary

Company overview and business model

• Operates as a Cayman Islands holding company with operations in China via a wholly owned PRC subsidiary, focusing on online marketing solutions for healthcare advertisers.

• Provides one-stop online marketing, specializing in short video ads through major Chinese platforms like Toutiao, Douyin, WeChat, and Weibo.

• Has served approximately 2,000 advertisers since 2018, with a majority from the healthcare sector.

• Utilizes proprietary data analysis software and maintains strong relationships with mainstream ad platforms.

Financial performance and metrics

• Revenue for the six months ended December 31, 2024: $23.95 million; net loss: $232,533.

• Fiscal year revenues: $48.52M (2024), $28.23M (2023), $16.16M (2022); net income: $1.29M (2024), $969,752 (2023), $244,587 (2022).

• Key performance indicators include impressions, click-throughs, and conversions, with significant year-over-year growth in ad impressions and conversions.

Use of proceeds and capital allocation

• Net proceeds will fund project development, business growth, working capital, and general corporate purposes.

• May allocate funds to acquisitions or investments in technologies, products, or businesses, though no current commitments exist.

• Management retains broad discretion over allocation of proceeds.